No difference among modern contrast media's effect on neointimal proliferation and restenosis after coronary stenting in pigs

被引:2
作者
Clauss, W [1 ]
Scheller, B
Schmitt, A
Sovak, M
Speck, U
机构
[1] Charite, Dept Radiol, D-10098 Berlin, Germany
[2] Schering AG, D-1000 Berlin, Germany
[3] Univ Saarland, D-6650 Homburg, Germany
[4] Univ Calif San Diego, Sch Med, Dept Radiol, San Diego, CA 92103 USA
关键词
restenosis; percutaneous transluminal coronary angiograph; contrast media; ionic; nonionic; isotonic contrast media; porcine coronarography; porcine stenting;
D O I
10.1097/01.rli.0000084954.62318.19
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: Recent clinical trials indicate that the choice of radiographic contrast media (CM) may influence the late outcome of coronary interventions. This might be explained by the different effects of various CM on neointimal proliferation. Methods: The effect of a 1-hour incubation of bovine aortic smooth muscle cells in ioxaglate or iopromide solution on in vitro cell division was tested. Furthermore, in 12 pigs randomized into 3 groups (iopromide, ioxaglate, and iosimenol; a novel nonionic dimer), coronary angiography was performed followed by implantation of stents. After 28 days, restenosis was assessed by quantitative angiography and histomorphometry. Results: Compared with saline, CM did no change cell counts up to 15 days after incubation. Baseline parameters in the pigs indicated no difference between the test groups. After 28 days, the test groups showed no significant differences in the parameters characterizing in-stent restenosis. Conclusions: Under the experimental conditions iopromide, ioxaglate, and iosimenol had no or very similar direct or otherwise mediated effect on cell proliferation and restenosis.
引用
收藏
页码:743 / 749
页数:7
相关论文
共 19 条
[1]   Restenosis: a challenge for pharmacology [J].
Bult, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) :274-279
[2]  
CUCHERAT M, 1999, CIRCULATION S
[3]   Randomized trial of contrast media utilization in high-risk PTCA - The COURT trial [J].
Davidson, CJ ;
Laskey, WK ;
Hermiller, JB ;
Harrison, JK ;
Matthai, W ;
Vlietstra, RE ;
Brinker, JA ;
Kereiakes, DJ ;
Muhlestein, JB ;
Lansky, A ;
Popma, JJ ;
Buchbinder, M .
CIRCULATION, 2000, 101 (18) :2172-2177
[4]   A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty [J].
Grines, CL ;
Schreiber, TL ;
Savas, V ;
Jones, DE ;
Zidar, FJ ;
Gangadharan, V ;
Brodsky, M ;
Levin, R ;
Safian, R ;
PuchrowiczOchocki, S ;
Castellani, MD ;
ONeill, WW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (06) :1381-1386
[5]  
Heldman AW, 2001, CIRCULATION, V103, P2289
[6]   Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology:: pathophysiology and clinical aspects [J].
Idée, JM ;
Corot, C .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (06) :613-623
[7]   Effects of locally administered argatroban on restenosis after balloon angioplasty: Experimental and clinical study [J].
Imanishi, T ;
Arita, M ;
Tomobuchi, Y ;
Hamada, M ;
Hano, T ;
Nishio, I .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (11) :800-806
[8]   Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction:: Possible topical application in malignant bile duct obstructions [J].
Kalinowski, M ;
Alfke, H ;
Kleb, B ;
Dürfeld, F ;
Wagner, HJ .
INVESTIGATIVE RADIOLOGY, 2002, 37 (07) :399-404
[9]   NONSPECIFIC INHIBITION OF ENZYMES BY ORGANIC CONTRAST MEDIA [J].
LANG, JH ;
LASSER, EC .
JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (03) :233-+
[10]   Ionic or non-ionic contrast media during coronary intervention: does it make a difference? [J].
Legrand, V .
EUROPEAN HEART JOURNAL, 2001, 22 (05) :353-354